Caricamento...
Clinical Impact of Selective and Non-selective Beta Blockers on Survival in Ovarian Cancer Patients
BACKGROUND: Preclinical evidence suggests that sustained adrenergic activation can promote ovarian cancer growth and metastasis. We examined the impact of beta-adrenergic blockade on clinical outcome of women with epithelial ovarian, primary peritoneal or fallopian tube cancers (collectively, EOC)....
Salvato in:
| Pubblicato in: | Cancer |
|---|---|
| Autori principali: | , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4575637/ https://ncbi.nlm.nih.gov/pubmed/26301456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29392 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|